islatravir
Jump to navigation
Jump to search
Indications
- use in combination with lenacapavir for once weekly treatment of HIV-1 infection
Mechanism of action
- nucleoside reverse transcriptase translocation inhibitor
More general terms
Component of
References
- ↑ Colson AE, Crofoot GE, Ruane PJ et al Once-Weekly Oral Islatravir Plus Lenacapavir Versus Daily Oral Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Persons With HIV-1 : A Phase 2 Randomized Study. Ann Intern Med. 2025 Dec 23. PMID: https://pubmed.ncbi.nlm.nih.gov/41429026